Combined effect of p53-armed oncolytic virus and immune checkpoint inhibitors in murine pancreatic cancer models

被引：0
|
作者：
Fujita, Shuto [1 ]
Tazawa, Hiroshi [1 ,2 ]
Kajiwara, Yoshinori [1 ]
Kikuchi, Satoru [1 ]
Kuroda, Shinji [1 ]
Noma, Kazuhiro [1 ]
Urata, Yasuo [3 ]
Kagawa, Shunsuke [1 ]
Fujiwara, Toshiyoshi [1 ]
机构：
[1] Okayama Univ, Grad Sch Med, Dept Surg Gastroenterol, Okayama, Japan
[2] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan
[3] Oncolys BioPharma Inc, Tokyo, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2182
引用
收藏
页码：961 / 961
页数：1
相关论文
共 46 条
  • [31] Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer
    Araki, Hiroyuki
    Tazawa, Hiroshi
    Kanaya, Nobuhiko
    Kajiwara, Yoshinori
    Yamada, Motohiko
    Hashimoto, Masashi
    Kikuchi, Satoru
    Kuroda, Shinji
    Yoshida, Ryuichi
    Umeda, Yuzo
    Urata, Yasuo
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    MOLECULAR THERAPY-ONCOLYTICS, 2022, 27 : 3 - 13
  • [32] Impact of serum anti-p53 antibody on efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Shimizu, T.
    Nakagawa, Y.
    Asai, Y.
    ANNALS OF ONCOLOGY, 2024, 35
  • [33] Oncolytic Adenovirus Armed with Multiple Immune Stimulatory Transgenes in Combination with PD-L1-Targeted Radioimmunotherapy Exert Synergistic Antitumor Effect Against Pancreatic Cancer
    Yun, Chae-Ok
    Yoon, A-Rum
    Lee, Jeongwon
    Seo, Jea Hyun
    MOLECULAR THERAPY, 2023, 31 (04) : 781 - 781
  • [34] Mutant-p53 amplifies Cxcl1 expression from distal enhancers blunting immune checkpoint inhibition efficacy in pancreatic cancer
    Mahat, Dig B.
    Kumra, Heena
    Metcalf, Emily
    Castro, Sarah
    Nguyen, Kim
    Singh, Arundeep
    Ho, William W.
    Chen, Ivy
    Sullivan, Brandon
    Yim, Leon
    Moiso, Enrico
    Chauhan, Vikash
    Silva, Hernandez Moura
    Spranger, Stefani
    Jain, Rakesh
    Sharp, Phillip A.
    CANCER RESEARCH, 2024, 84 (02)
  • [35] Effect and safety analysis of immune checkpoint inhibitors (Bevacizumab and Pimumab) combined with nutritional support on survival in patients with DMMR recurrent endometrial cancer
    Du, Zhixiang
    Wang, Na
    Wang, Xu
    Wei, Xurui
    Wang, Yujing
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S378 - S379
  • [36] Expression by immunohistochemistry of p53 tumor suppressor protein as a predictive biomarker of response to immune checkpoint inhibitors in non-small cell lung cancer
    Olivares Hernandez, A.
    del Barco, E.
    Figuero Perez, L.
    Escala Cornejo, R. A.
    Parra Perez, M. C.
    Rodrigues Francoso, A.
    Bellido Hernandez, L.
    Vidal Tocino, R.
    Escalera Martin, E.
    Claros Ampuero, J.
    Teran Brage, E.
    Lopez Gutierrez, A.
    Ludena de la Cruz, M. D.
    Cruz-Hernandez, J. J.
    ANNALS OF ONCOLOGY, 2021, 32 : S850 - S850
  • [37] Effect of oncolytic vaccinia virus-induced IL-7 and IL-12 expression on tumor immune microenvironment in poorly immunogenic murine cancer
    Nakao, Shinsuke
    Arai, Yukinori
    Tasaki, Mamoru
    Yamashita, Midori
    Amino, Nobuaki
    Murakami, Ryuji
    Kawase, Tatsuya
    Nakatake, Motomu
    Kurosaki, Hajime
    Mori, Masamichi
    Takeuchi, Masahiro
    Nakamura, Takafumi
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [38] DT-9081, A SELECTIVE EP4 RECEPTOR ANTAGONIST WHICH SYNERGIZES WITH IMMUNE CHECKPOINT INHIBITORS TO INDUCE COMPLETE RESPONSES IN SYNGENEIC MURINE CANCER MODELS
    Blayo, Anne-Laure
    Jouffroy-Zeller, Claire
    Lenne, Nathalie
    Nafia, Imane
    Zerr, Patricia
    Schann, Stephan
    Leroy, Xavier
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A850 - A850
  • [39] In vivo synergy of 90Y-NM600 and Bempegaldesleukin improves anti-tumor efficacy of immune checkpoint inhibitors in syngeneic murine cancer models.
    Sumiec, Elizabeth G.
    Bates, Amber M.
    Hernandez, Reinier
    Grudzinski, Joseph J.
    Marsh, Ian R.
    Emma, Sarah E.
    Nystuen, Erin J.
    Jagodinsky, Justin C.
    Pieper, Alexander A.
    Sosa, Gustavo A.
    Bednarz, Bryan P.
    Patel, Ravi B.
    Weichert, Jamey
    Morris, Zachary S.
    CANCER RESEARCH, 2021, 81 (13)
  • [40] Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patients
    Hirasawa, Yuya
    Kubota, Yutaro
    Mura, Emiko
    Suzuki, Risako
    Tsurui, Toshiaki
    Iriguchi, Nana
    Ishiguro, Tomoyuki
    Ohkuma, Ryotaro
    Shimokawa, Masahiro
    Ariizumi, Hirotsugu
    Horiike, Atsushi
    Wada, Satoshi
    Yamashita, Takeshi
    Ariyoshi, Tomotake
    Goto, Satoru
    Otsuka, Koji
    Murakami, Masahiko
    Kiuchi, Yuji
    Yoshimura, Kiyoshi
    Tsunoda, Takuya
    FRONTIERS IN ONCOLOGY, 2024, 14
12345